Padariya Monikaben, Daniels Alison, Tait-Burkard Christine, Hupp Ted, Kalathiya Umesh
International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdansk, Poland.
Department of Infectious Disease, Edinburgh, Scotland EH4 2XR, United Kingdom; The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, United Kingdom.
Biomed Pharmacother. 2022 Jul;151:113190. doi: 10.1016/j.biopha.2022.113190. Epub 2022 May 24.
The structural spike (S) protein from the SARS-CoV-2 β-coronavirus is shown to make different pre- and post-fusion conformations within its homotrimer unit. To support the ongoing novel vaccine design and development strategies, we report the structure-based design approach to develop self-derived S peptides. A dataset of crucial regions from the S protein were transformed into linear motifs that could act as the blockers or stabilizers for the S protein homotrimer unit. Among these distinct S peptides, the pep02 (537-QQFGRDIAD-545) and pep07 (821-RDLICAQKFNGLTVLPPLLTDE-842) were found making stable folded binding with the S protein (550-750 and 950-1050 regions). Upon inserting SARS-CoV-2 S variants in the peptide destabilized the complexed S protein structure, resulting an allosteric effect in different functional regions of the protein. Particularly, the molecular dynamics revealed that A544D mutation in the pep02 peptide induced instability for the complexed S protein, whereas the N943K variant from pep09 exhibited an opposite behavior. An increased protein-peptide binding affinity and the stable structural folding were observed in mutated systems, compared to that of the wild type systems. The presence of mutation has induced an "up" active conformation of the spike (RBD) domain, responsible for interacting the host cell receptor. Among the lower affinity peptide datasets (e.g., pep01), the S1 and S2 subunit in the protein formed an "open" conformation, whereas with higher affinity peptides (e.g., pep07) these domains gained a "closed" conformation. These findings propose that our designed self-derived S peptides could replace a single S protein monomer, blocking the homotrimer formation or inducing stability.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)β冠状病毒的结构刺突(S)蛋白在其三聚体单元内呈现出不同的融合前和融合后构象。为支持正在进行的新型疫苗设计和开发策略,我们报告了基于结构的设计方法来开发自源性S肽。来自S蛋白关键区域的数据集被转化为线性基序,这些基序可作为S蛋白三聚体单元的阻断剂或稳定剂。在这些不同的S肽中,发现pep02(537-QQFGRDIAD-545)和pep07(821-RDLICAQKFNGLTVLPPLLTDE-842)与S蛋白(550-750和950-1050区域)形成稳定的折叠结合。在肽中插入SARS-CoV-2 S变体使复合S蛋白结构不稳定,从而在该蛋白的不同功能区域产生变构效应。特别是,分子动力学显示pep02肽中的A544D突变导致复合S蛋白不稳定,而pep09中的N943K变体表现出相反的行为。与野生型系统相比,在突变系统中观察到蛋白质-肽结合亲和力增加和结构折叠稳定。突变的存在诱导了刺突(RBD)结构域的“向上”活性构象,负责与宿主细胞受体相互作用。在低亲和力肽数据集(例如pep01)中,蛋白质中的S1和S2亚基形成“开放”构象,而与高亲和力肽(例如pep07)结合时,这些结构域获得“封闭”构象。这些发现表明,我们设计的自源性S肽可以替代单个S蛋白单体,阻断三聚体形成或诱导稳定性。